Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022

Go back to Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
(NASDAQ: SPRB) Delayed: 43.99 -1.16 (2.57%)
Previous Close $45.15    52 Week High $ 
Open $45.47    52 Week Low $ 
Day High $45.47    P/E N/A 
Day Low $43.62    EPS $ 
Volume 66,482